Predictors of Psoriasis Area and Severity Index 100 response in Korean patients with moderate-to-severe plaque psoriasis receiving biologics
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- SCIEScopus
- 저널 순위
- JCR Q2Scopus Q3
- 저널
- EUROPEAN JOURNAL OF DERMATOLOGY33(5) · pp.518 · 2023
- 피인용
- Web of Science 6Scopus 6
- FWCI (Scopus)
- 1.01
- JCR IF
- JCR 2022 2.5
- ISSN
- 1167-1122
저자
- 김태림제1저자Pusan Natl Univ, Sch Med, Dept Dermatol, Busan, South Korea
- 원유미Pusan Natl Univ, Sch Med, Dept Dermatol, Busan, South Korea
- 김연아Pusan Natl Univ, Sch Med, Dept Dermatol, Busan, South Korea
- 원상현Pusan Natl Univ, Sch Med, Dept Dermatol, Busan, South Korea
- 배경남Pusan Natl Univ, Sch Med, Dept Dermatol, Busan, South Korea
- 이정수Pusan Natl Univ, Sch Med, Dept Dermatol, Busan, South Korea
- 신기혁Pusan Natl Univ, Sch Med, Dept Dermatol, Busan, South Korea
- 김훈수Pusan Natl Univ, Sch Med, Dept Dermatol, Busan, South Korea
- 고현창Pusan Natl Univ, Sch Med, Dept Dermatol, Busan, South Korea
- 김문범Pusan Natl Univ, Sch Med, Dept Dermatol, Busan, South Korea
- 김병수교신저자Pusan Natl Univ, Sch Med, Dept Dermatol, Busan, South Korea
초록
The Psoriasis Area and Severity Index (PASI) 100 response rate after treatment with biologics is reportedly lower in Asians than non-Asians. Large-scale studies evaluating predictors of PASI 100 response in Korean patients with psoriasis are yet to be conducted. To identify predictors of patients achieving PASI 100 response after 48-52 weeks of treatment with a biological agent. We retrospectively reviewed the medical records of 145 patients with psoriasis treated with a single biological agent for over one year. Clinical features were compared between super-responders (defined as achieving PASI 100 at 48-52 weeks) and non-super-responders. Among the patients included in the study, 61 (42.1%) were super-responders. No statistical difference in demographics and face, scalp, or nail involvement was observed. However, the mean body mass index (BMI) and baseline PASI were lower in super-responders (24.3 kg/m2, 14.3) than in non-super-responders (26.1 kg/m2, 16.2). There were more biologically naïve patients among the super-responders (85.2%) than the non-super-responders (67.9%). In Korean patients with moderate-to-severe psoriasis, a better PASI 100 response is expected for patients who are biologically naïve with a relatively lower baseline BMI and PASI.
키워드
biological agentPASI 100psoriasisDRUG SURVIVALTHERAPYASSOCIATIONPREVALENCEOBESITYCOHORT
식별자
- Scopus EID
- 2-s2.0-85183804395
- WoS UID
- 001202074700005



로그인
연구물 목록으로